LYRBX | VMVAX | LYRBX / VMVAX | |
Total Expense Ratio | 1.24 | 0.07 | 1,771% |
Annual Report Gross Expense Ratio | 1.71 | 0.07 | 2,443% |
Fund Existence | 11 years | 14 years | - |
Gain YTD | 0.000 | -0.596 | - |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.08B | 30.8B | 4% |
Annual Yield % from dividends | 0.00 | 2.33 | - |
Returns for 1 year | 2.56 | 4.97 | 52% |
Returns for 3 years | 17.97 | 7.78 | 231% |
Returns for 5 years | 179.21 | 114.64 | 156% |
Returns for 10 years | 58.72 | 78.23 | 75% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LCG | 28.37 | 0.42 | +1.50% |
Sterling Capital Focus Equity ETF | |||
SAMT | 29.63 | 0.26 | +0.90% |
Strategas Macro Thematic Opp ETF | |||
CGSD | 25.81 | -0.01 | -0.04% |
Capital Group Short Duration Income ETF | |||
VGSH | 58.48 | -0.03 | -0.05% |
Vanguard Short-Term Treasury ETF | |||
TSLQ | 38.01 | -4.44 | -10.46% |
Tradr 2X Short TSLA Daily ETF |